Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Lymphoma 57Lymphoma, Large B-Cell, Diffuse 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Lymphoma, Follicular 33Leukemia 30Lymphoma, Non-Hodgkin 28Burkitt Lymphoma 19Hodgkin Disease 18Neuroblastoma 13Lymphoma, Large-Cell, Immunoblastic 12Central Nervous System Neoplasms 12Sarcoma 10Multiple Myeloma 10Lymphoma, Mantle-Cell 10Rhabdomyosarcoma 9Wilms Tumor 7Lymphoma, T-Cell, Peripheral 7Lymphoma, Large-Cell, Anaplastic 7Lymphoma, B-Cell, Marginal Zone 7Oligodendroglioma 6Neuroectodermal Tumors, Primitive, Peripheral 5Neoplasms, Plasma Cell 5Neoplasms 5Malignant mesenchymal tumor 5Leukemia, Lymphocytic, Chronic, B-Cell 5Brain Neoplasms 5Astrocytoma 5Retinoblastoma 4Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

Vincristine 1Topotecan 1Razoxane 1Ifosfamide 1Etoposide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Localized Extraskeletal Ewing Sarcoma × Vincristine × Clear all
NCT01231906 2026-01-23

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

Children's Oncology Group

Phase 3 Completed
642 enrolled 11 charts
Sarcoma

Localized Extraskeletal Ewing Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡